Find your path to Freddie
Sign up to see every warm intro you have to Freddie
- Paths you didn't know you had: your email and LinkedIn already hold routes to Freddie. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Principal at Monograph who was part of the founding team of portfolio company Ascend Advanced Therapies and sits on the board of Nocion Therapeutics. Previously an Investment Partner at Syncona and part of the Wellcome Trust investment team.
Contact· self-published, not guessed
Deals · 1
Nocion TherapeuticsBoard seat
via Monograph Capital Partners · filed Mar 2026 · $23M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Sources: SEC Form D filings · curated public sources.
Colleagues at Monograph Capital Partners
Frequently asked questions
- Who is Freddie Dear?
- Principal at Monograph who was part of the founding team of portfolio company Ascend Advanced Therapies and sits on the board of Nocion Therapeutics. Previously an Investment Partner at Syncona and part of the Wellcome Trust investment team.
- Where does Freddie Dear work?
- Freddie Dear is Principal (Portfolio) at Monograph Capital Partners.
- What boards does Freddie Dear sit on?
- Freddie Dear holds tracked board seats at Nocion Therapeutics.
- What companies has Freddie Dear invested in?
- Investments tracked here include Dayjob.
About this profile. Compiled from public sources — Monograph Capital Partners's own website, regulatory filings and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights








